Appointment of Secretarial Auditor
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals announced that shareholders at the 42nd Annual General Meeting held on September 9, 2025 approved the appointment of M/s Rishi Mittal & Associates, Practicing Company Secretaries (Amritsar), as the company's Secretarial Auditor. The appointment is for a term of five consecutive years, covering FY 2025-26 through FY 2029-30. The firm holds a Peer Review Certificate (No. 2486/2022) and provides secretarial, legal, compliance, and corporate governance services. This is a routine statutory appointment under SEBI listing regulations.
This is a standard regulatory compliance announcement with no material impact on shareholders or stock price. It simply ensures the company has a qualified secretarial auditor in place for the next five years, supporting ongoing governance and compliance.